Join
Live feed
·
INSIDERFilingvia Quantisnow
Adaptive Biotechnologies Corporation logo

Chief Commercial Officer, MRD Bobulsky Susan sold $31,176 worth of shares (1,299 units at $24.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.32% to 399,989 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ADPT· Adaptive Biotechnologies Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADPT (Adaptive Biotechnologies Corporation) and more on Quantisnow.